News
Federal health agencies were alerted in February 2021 to “large reports of myocarditis” in young people who received the Pfizer vaccine, but waited until late June to adjust the ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
6d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising, but approval could be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed ...
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
Amid concerns over reports of mild Covid-19 cases emerging in some parts of India, questions have been arising over whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results